$10 Billion Deal, page-12979

If they can't get the results out this quarter - or the results are not an improvement on previous results released. then it won't matter as the SP will not exceed the exercise price of the options. Which is what people have been saying.

Not feasible that the options will be taken up.

Pressure on the SP over the last month would indicate that the market is somewhat unimpressed. Normally, FOMO would be in full play - and it is concerning that it isn't.

BIT is up to its old tricks - overpromising on deadlines and potential commercial deals - PLUS, complete absence of any updates for shareholders.

Contrary to those who would try to convince others (maybe themselves), the delays are not good signs. Any delays in releasing trial results beyond this quarter would seriously erode holders' confidence in BIT management to manage their operations or maybe, even understand those operations.

Worse that even that, a failure by BIT to also come clean with news on a commercial deal will damage the SP - and well beyond November. A CR will definitely be required before November under those circumstances. $1.2mil at the start of the quarter is LESS than the R&D rebate they received so, without the R&D rebate, they would be underwater financially at the end of March. Now, by procrastination, any CR has become more urgent as available funds become more constrained. Appallingly bad financial management.